News

Mankind Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹2379. The stock has experienced fluctuations today, with a low ...
These debentures will be issued in three to four distinct series with maturities of up to 48 months Mankind Pharma fund raising committee finalised a comprehensive plan to issue non-convertible ...
After the closure of the reporting period, your Company has allotted 46,698 equity shares on May 10, 2024 to the eligible employees under Mankind Employee Stock Option Plan 2022. As on the date of ...
The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.